Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes
Gottfrid Sjödahl(Lund University), Fredrik Liedberg(Lund University), Johan Abrahamsson(Lund University), Mattias Höglund(Lund University), Petter Kollberg(Lund University), Gunilla Chebil(Lund University), Karin Holmsten(Karolinska Institutet), Iva Johansson(Sahlgrenska University Hospital), Nour‐Al‐Dain Marzouka(Khalifa University of Science and Technology), Anders Ullén(Inserm), Pontus Eriksson(Lund University), Hans Olsson(Linköping University), Claes Lindh(Karolinska Institutet), Kristina Lövgren(Lund University), Carina Bernardo(Lund University)
Cited by 26
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660